Home Assessing the efficacy and safety of Unani pharmacopoeial formulations in dermatophytosis (quba) – a randomized controlled trial
Article
Licensed
Unlicensed Requires Authentication

Assessing the efficacy and safety of Unani pharmacopoeial formulations in dermatophytosis (quba) – a randomized controlled trial

  • Saima Naseem , Mohammad Nawab ORCID logo EMAIL logo , Syeda Hajra Fatima ORCID logo , Ahmed Minhajuddin and Asif Ahmad Khan
Published/Copyright: August 24, 2022

Abstract

Objectives

The recent trends of rising unresponsive cases of dermatophytosis to conventional therapies pose a challenge in clinical practice. Unani medicine offers effective treatment for dermatophytosis. This study aimed to evaluate the efficacy and safety of the Unani herbo-mineral preparations Qurs-e-Asfar (QA) and Rogan-e-Narjeel (RN) in dermatophytosis.

Methods

This was a randomized, active-controlled and open-label clinical study. The participants diagnosed with dermatophytosis (n=78) randomized into treatment group (n=40) receiving oral QA (778 mg twice a day) and topical RN and control group (n=38) receiving oral Itraconazole (100 mg/day) and topical Terbinafine hydrochloride (1%) for 6 weeks.

Results

We found post-treatment improvement in itching by 86.3% vs. 78% (treatment vs. control group), erythema by 96.4% vs. 94.3%, scaling by 93% vs. 92.2% and peripheral raised margins by 82.3% vs. 81%. Furthermore, this study showed that the differences in the mean Total Signs and Symptoms Score (TSSS) and positive KOH mount were clinically and statistically significant (p<0.05) in both the groups. On comparing inter group, the differences in mean TSSS (p=0.07) and positive KOH mount (p=0.717) were found statistically insignificant.

Conclusions

This study concludes that the formulations QA and RN were effective and safe in the treatment of dermatophytosis.


Corresponding author: Mohammad Nawab, Department of Moalajat (Medicine), National Research Institute of Unani Medicine for Skin Disorders, Opp. ESI Hospital, Eragadda, Hyderabad 500032, India, E-mail:

Acknowledgments

We are thankful to Director General, Central Council for Research in Unani Medicine, Ministry of AYUSH, Government of India, New Delhi for providing necessary financial support for this study.

  1. Research funding: This study was sponsored by Central Council for Research in Unani Medicine, Ministry of AYUSH, Government of India, New Delhi, as an academic activity required for submission of post graduate dissertation.

  2. Author contribution: Saima Naseem designed the study, developed protocol and case record form and conducted the study. Syeda Hajra Fatima examined pathological markers and KOH mount for skin scrapings. Ahmed Minhajuddin conceptualized the study. Asif Ahmad Khan drafted the manuscript. Mohammad Nawab developed protocol, evaluated the outcome, analysed the data and edited the manuscript.

  3. Competing interest: Authors state no conflict of interest.

  4. Informed consent: Informed consent was obtained from all individuals included in this study.

  5. Ethical approval: This study was approved by the Institutional Ethics Committe and registered prospectively on 21/04/2020 in the Clinical Trial Registry-India (CTRI) under CTRI number-CTRI/2020/04/024765.

  6. Data availability: The datasets generated during and/or analysed during the current study are available from the corresponding author on reasonable request.

References

1. Aaliya, Nawab, M, Kazmi, MH, Ayyub, S. A randomized active controlled clinical trial to evaluate safety and efficacy of a topical unani formulation Marham Kharish Jadeed in the management of Qūbā (tinea corporis). Cell Med 2020;10:1–7. https://doi.org/10.5667/CellMed.2020.0022.Search in Google Scholar

2. Aaliya, Nawab, M, Ayyub, S, Kazmi, MH. Therapeutic approach and management of Quba in the perspective of unani medicine. Hippocrat J Unani Med 2020;15:1–11.Search in Google Scholar

3. Fonseka, S, Bandara, DDJ, Wickramaarachchi, DC, Narankotuwa, NGKHH, Kumarasiri, PVR. Treatment of difficult-to-treat-dermatophytosis: results of a randomized, double-blind, placebo-controlled study. J Infect Dev Ctries 2021;15:1731–7. https://doi.org/10.3855/jidc.14666.Search in Google Scholar PubMed

4. Das, A, Sil, A, Sarkar, TK, Sen, A, Chakravorty, S, Sengupta, M, et al.. A randomized, double-blind trial of amorolfine 0.25% cream and sertaconazole 2% cream in limited dermatophytosis. Indian J Dermatol Venereol Leprol 2019;85:276–81. https://doi.org/10.4103/ijdvl.ijdvl_907_17.Search in Google Scholar PubMed

5. Sharma, P, Bhalla, M, Thami, GP, Chander, J. Evaluation of efficacy and safety of oral terbinafine and itraconazole combination therapy in the management of dermatophytosis. J Dermatol Treat 2020;31:749–53. https://doi.org/10.1080/09546634.2019.1612835.Search in Google Scholar PubMed

6. Saumya, P, Shyam, V. The menace of dermatophytosis in India: the evidence that we need. Indian J Dermatol Venereol Leprol 2017;83:281–4. https://doi.org/10.4103/ijdvl.ijdvl_224_17.Search in Google Scholar

7. Degreef, H. Clinical forms of dermatophytosis (ringworm infection). Mycopathologia 2008;166:257–65. https://doi.org/10.1007/s11046-008-9101-8.Search in Google Scholar PubMed

8. Tabri, A. Moalajat-e-Buqratiya (urdu translation by CCRUM). New Delhi: Central Council for Research in Unani Medicine; 1997, vol. 2:211–3 pp.Search in Google Scholar

9. Anonymous. Standard Unani medical terminology. New Delhi: Central Council for Research in Unani Medicine; 2012:297 p.Search in Google Scholar

10. Majusi, AbA. Kamil al sana’a al-Tibbiya. New Delhi: Central Council for Research in Unani Medicine; 2005, vol 2.Search in Google Scholar

11. Bishnoi, A, Vinay, K, Dogra, S. Emergence of recalcitrant dermatophytosis in India. Lancet Infect Dis 2018;18:250–1. https://doi.org/10.1016/S1473-3099(18)30079-3.Search in Google Scholar PubMed

12. Singh, S, Chandra, U, Anchan, VN, Verma, P, Tilak, R. Limited effectiveness of four oral antifungal drugs (fluconazole, griseofulvin, itraconazole and terbinafine) in the current epidemic of altered dermatophytosis in India: results of a randomized pragmatic trial. Br J Dermatol 2020;183:840–6. https://doi.org/10.1111/bjd.19146.Search in Google Scholar PubMed

13. Anonymous. National formulary of Unani medicine part V. New Delhi: Central Council for Research in Unani Medicine, Govt. of India, Ministry of Health and Family Welfare; 2006, vol V. 20 p.Search in Google Scholar

14. Anonymous. National formulary of Unani medicine, part IV. New Delhi: Central Council for Research in Unani Medicine, Department of AYUSH, Ministry of Health and Family Welfare, Govt. of India; 2006, vol 19. 33 p.Search in Google Scholar

15. Ghani, H. Khazāin al-Advia. New Delhi: Idāra Kitāb al-Shifā; 2011.Search in Google Scholar

16. Kabeeruddin, H. Makhzanul Mufridat Al Maroof khawasul Advia. Deoband: Faisal Publications Jama Masjid; 2000.Search in Google Scholar

17. Khalid Thebo, N, Ahmed Simair, A, Sughra Mangrio, G, Ansari, K, Ali Bhutto, A, Lu, C, et al.. Antifungal potential and antioxidant efficacy in the shell extract of Cocos nucifera (L.) (arecaceae) against pathogenic dermal mycosis. Medicines 2016;3:1–12. https://doi.org/10.3390/medicines3020012.Search in Google Scholar PubMed PubMed Central

18. Tariq, N. Taj al Mufradat. New Delhi: Idara Kitab-us-Shifa; 2010.Search in Google Scholar

19. Miraj, S, Kiani, S. Bioactivity of Sesamum indicum: a review study. Der Pharm Lett 2016;8:328–34.Search in Google Scholar

20. Mathur, R, Swaminathan, S. National ethical guidelines for biomedical and Health research involving human participants, 2017: a commentary. Indian journal of medical ethics 2018;3:201–4. https://doi.org/10.20529/ijme.2018.065.Search in Google Scholar

21. Anonymous. Good clinical practice guidelines for clinical trials in ayurveda siddha and Unani medicine. New Delhi: Department of AYUSH, Ministry of Health & Family Welfare, Government of India; 2013.Search in Google Scholar

22. Faul, F, Erdfelder, E, Lang, AG, Buchner, A. G*Power 3: a flexible statistical power analysis for the social, behavioral, and biomedical sciences. Behav Res Methods 2007;39:175–91. https://doi.org/10.3758/bf03193146.Search in Google Scholar PubMed

23. Sealed Envelope Ltd. Create a blocked randomisation list; 2021. [Online] [Internet]. Available from: https://sealedenvelope.com/simple-randomiser/v1/lists [Accessed 19 Mar 2021].Search in Google Scholar

24. Lone, AH, Ahmad, T, Anwar, M, Sofi, G. Clinical efficacy and safety of a pharmacopial polyherbal unani formulation in pityriasis versicolor: a comparative randomized single-blind study. J Alternative Compl Med 2012;18:978–82. https://doi.org/10.1089/acm.2011.0520.Search in Google Scholar PubMed

25. Theplantlist. The plant list, 2013 version 1.1; 2021. Published on the internet [Internet]. Available from: http://www.theplantlist.org/ [Accessed 19 Mar 2021].Search in Google Scholar

26. WFO. World flora online; 2021. Published on the Internet [Internet]. Available from: http://www.worldfloraonline.org [Accessed 19 Mar 2021].Search in Google Scholar

27. Robert, R, Pihet, M. Conventional methods for the diagnosis of dermatophytosis. Mycopathologia 2008;166:295–306. https://doi.org/10.1007/s11046-008-9106-3.Search in Google Scholar PubMed

28. Hasan, TSS, Shagufta, A, Tabassum, L. Clinical evaluation of efficacy of majoon ushba and marham gulabi in qooba (dermatophytosis). Indian J Tradit Knowl 2011;10:702–5.Search in Google Scholar

29. Mastan, A. Evaluation of mycological cure of Unani medicine vs. modern medicine: a comparative clinical trial. J Ayurvedic Herb Med 2020;6:108–10. https://doi.org/10.31254/jahm.2020.6301.Search in Google Scholar

30. Bhatia, A, Kanish, B, Badyal, DK, Kate, P, Choudhary, S. Efficacy of oral terbinafine versus itraconazole in treatment of dermatophytic infection of skin – a prospective, randomized comparative study. Indian J Pharmacol 2019;51:116–9. https://doi.org/10.4103/ijp.ijp_578_17.Search in Google Scholar PubMed PubMed Central

31. Chatterjee, D, Ghosh, SK, Sen, S, Sarkar, S, Hazra, A, De, R. Efficacy and tolerability of topical sertaconazole versus topical terbinafine in localized dermatophytosis: a randomized, observer-blind, parallel group study. Indian J Pharmacol 2016;48:659–64. https://doi.org/10.4103/0253-7613.194850.Search in Google Scholar PubMed PubMed Central

32. Ahmad, K, Ahmad, H, Hafiz, KA. Neela Thotha (Copper sulphate): an important mineral drug of Unani medicine to be used in the management of various ailments. J Drug Deliv Therapeut 2021;11:179–84. https://doi.org/10.22270/jddt.v11i2-s.4819.Search in Google Scholar

33. Massalimov, IA, Medvedev, UA, Zaynitdinova, RM, Mufazalova, NA, Mustafin, AG. Assessment of antifungal activity of micronized and nanosized elemental sulfur. Nanotechnol Nanosci 2012;3:55–8.Search in Google Scholar

Received: 2022-04-14
Revised: 2022-05-14
Accepted: 2022-05-30
Published Online: 2022-08-24

© 2022 Walter de Gruyter GmbH, Berlin/Boston

Articles in the same Issue

  1. Frontmatter
  2. Editorial
  3. Pharmacogenetics and ethnicity: “Dr. José María Cantú” award announcement
  4. Review
  5. A review of pharmacogenetic studies in the Bangladeshi population
  6. Original Articles
  7. The ANKK1/DRD2 gene TaqIA polymorphism (rs1800497) is associated with the severity of extrapyramidal side effects of haloperidol treatment in CYP2D6 extensive metabolizers with schizophrenia spectrum disorders
  8. Effect of CYP2D6*4, CYP2D6*10 polymorphisms on the safety of treatment with timolol maleate in patients with glaucoma
  9. Actionable mutations in non-small cell lung cancer in patients at hospital de Especialidades Eugenio Espejo, Ecuador 2017–2020
  10. Impact of FCGR2A R131H, FCGR3A F158V and FCGR3B NA1/NA2 polymorphisms on response to Fc-containing TNF inhibitors in Tunisian rheumatoid arthritis patients
  11. CYP2C9 gene polymorphisms influence on antihypertensive effectiveness and hypouricemic effect of losartan among patients with arterial hypertension: an observational study
  12. Assessing the efficacy and safety of Unani pharmacopoeial formulations in dermatophytosis (quba) – a randomized controlled trial
  13. Quantitative assessment of antioxidant potential of selected homeopathic preparations in clinical practice
  14. Influence of EPHX1 c.337 T>C and UGT2B7*2 genetic polymorphisms on the requirement of carbamazepine maintenance dose in persons with epilepsy (PWE) of Southern part of India: a cross-sectional genetic association study
  15. Cathine and cathinone disposition kinetics and neurotransmitter profile in several organs of rats exposed to a single dose of Catha edulis (Vahl) Forssk. ex Endl. extract
Downloaded on 8.11.2025 from https://www.degruyterbrill.com/document/doi/10.1515/dmpt-2022-0125/html
Scroll to top button